RaySearch Laboratories AB (publ) (RSLBF)
OTCMKTS · Delayed Price · Currency is USD
32.05
0.00 (0.00%)
Jul 18, 2025, 4:00 PM EDT
RaySearch Laboratories AB Revenue
RaySearch Laboratories AB had revenue of 331.70M SEK in the quarter ending March 31, 2025, with 28.97% growth. This brings the company's revenue in the last twelve months to 1.27B, up 20.72% year-over-year. In the year 2024, RaySearch Laboratories AB had annual revenue of 1.19B with 16.62% growth.
Revenue (ttm)
1.27B SEK
Revenue Growth
+20.72%
P/S Ratio
10.29
Revenue / Employee
3.04M SEK
Employees
416
Market Cap
1.30B USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | 169.87M | 16.62% |
Dec 31, 2023 | 1.02B | 178.51M | 21.16% |
Dec 31, 2022 | 843.65M | 201.98M | 31.48% |
Dec 31, 2021 | 641.67M | -9.94M | -1.53% |
Dec 31, 2020 | 651.61M | -89.97M | -12.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
RaySearch Laboratories AB News
- 4 days ago - Invitation to presentation of RaySearch's interim report for the second quarter of 2025 - PRNewsWire
- 2 months ago - RaySearch Laboratories reports interim report for January 1 to March 31, 2025 - Seeking Alpha
- 2 months ago - Interim report January 1 - March 31, 2025: RaySearch Laboratories - PRNewsWire
- 2 months ago - RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO - PRNewsWire
- 3 months ago - Invitation to presentation of RaySearch's interim report for the first quarter of 2025 - PRNewsWire
- 4 months ago - Completed placing of shares in RaySearch Laboratories AB (publ) - PRNewsWire
- 4 months ago - Contemplated placement of existing shares in RaySearch Laboratories AB - PRNewsWire
- 5 months ago - RaySearch Laboratories reports Q4 results - Seeking Alpha